These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 707294)
1. Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension. Daoud FS; Reeves JT; Kelly DB Am J Cardiol; 1978 Nov; 42(5):817-22. PubMed ID: 707294 [No Abstract] [Full Text] [Related]
2. Primary pulmonary hypertension; favorable effect of isoproterenol. Shettigar UR; Hultgren HN; Specter M; Martin R; Davies DH N Engl J Med; 1976 Dec; 295(25):1414-5. PubMed ID: 980096 [No Abstract] [Full Text] [Related]
3. Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response. Rich S; Martinez J; Lam W; Levy PS; Rosen KM Am Heart J; 1983 Jan; 105(1):119-27. PubMed ID: 6849224 [No Abstract] [Full Text] [Related]
4. Primary pulmonary hypertension in a child. Response to pharmacologic agents. Satyanarayana Rao BN; Moller JH; Edwards JE Circulation; 1969 Oct; 40(4):583-7. PubMed ID: 5823553 [No Abstract] [Full Text] [Related]
5. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension. Ziegler JW; Ivy DD; Wiggins JW; Kinsella JP; Clarke WR; Abman SH Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1388-95. PubMed ID: 9817684 [TBL] [Abstract][Full Text] [Related]
6. Unpredictable response to vasodilator therapy in primary pulmonary hypertension. Schmiedt MI; Shettigar UR; Siddique M; Barbier G; Bialow M; Carranza S Int J Clin Pharmacol Ther; 1998 Aug; 36(8):435-40. PubMed ID: 9726697 [TBL] [Abstract][Full Text] [Related]
7. A problem in pulmonary hypertension. 1. The clinical course. A clinicopathologic conference from the Division of Pulmonary Diseases, Hahnemann Medical College and Hospital, Philadelphia. Chest; 1974 Jan; 65(1):69-75 contd. PubMed ID: 4809335 [No Abstract] [Full Text] [Related]
8. Isoproterenol in massive pulmonary embolism: haemodynamic and clinical effects. McDonald IG; Hirsh J; Hale GS; Cade JF; McCarthy RA Med J Aust; 1968 Aug; 2(5):201-5. PubMed ID: 5676200 [No Abstract] [Full Text] [Related]
9. Pulmonary vascular resistance in neonatal swine: response to right pulmonary artery occlusion, isoproterenol, and prostaglandin E1. Crombleholme TM; Adzick NS; Longaker MT; Bradley SM; Duncan BW; Jennings R; Verrier ED; Harrison MR J Pediatr Surg; 1990 Aug; 25(8):861-6. PubMed ID: 2401941 [TBL] [Abstract][Full Text] [Related]
12. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation. Opitz CF; Wensel R; Bettmann M; Schaffarczyk R; Linscheid M; Hetzer R; Ewert R Eur Heart J; 2003 Feb; 24(4):356-65. PubMed ID: 12581683 [TBL] [Abstract][Full Text] [Related]
13. Effect of vasodilators on pulmonary vascular resistance in patients with pulmonary hypertension. Zaloga GP; Chernow B; Holt MR; Hughes P; Pilley MP; Rainey TG; Lake CR Clin Pharm; 1983; 2(3):265-8. PubMed ID: 6192967 [No Abstract] [Full Text] [Related]
14. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension]. Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506 [TBL] [Abstract][Full Text] [Related]
15. Adverse effect of hydralazine in patients with primary pulmonary hypertension. Kronzon I; Cohen M; Winer HE JAMA; 1982 Jun; 247(22):3112-4. PubMed ID: 7077805 [No Abstract] [Full Text] [Related]